Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Surface Plasmon Resonance Market, By Product, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1515560
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 352 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,459,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,380,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,752,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸®Æ÷Æ® ÇÏÀ̶óÀÌÆ®

Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 11¾ï 2,520¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2024-2032³â CAGR 5.50%·Î È®´ë

Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå - ½ÃÀå ¿ªÇÐ

Ç¥¸é ÇöóÁî¸ó °ø¸íÀÇ ½Å¾à°³¹ß ºÐ¾ß Àû¿ë È®´ë

ÁÖ¿ä ¾÷°è ±â¾÷ÀÇ Ç¥¸é ÇöóÁî¸ó °ø¸í Ȱ¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ Áß Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀåÀ» ÃËÁøÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. Ç¥¸é ÇöóÁî¸ó °ø¸í ±â¼úÀº ¾à¹° ¹ß°ß ¹× ¾à¹° °³¹ß¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ÀúºÐÀÚ ÀǾàǰÀÇ ¿¬±¸ ¹× °³¹ßÀº Ç×»ó ¼º°øÀûÀÌÁö ¾ÊÀº ºñ¿ë°ú ½Ã°£ÀÌ ¸¹ÀÌ ¼Ò¿äµÇ´Â ³ë·ÂÀ¸·Î Àνĵǰí ÀÖ½À´Ï´Ù. Ç¥¸é ÇöóÁî¸ó °ø¸íÀº Ç¥Àû ½Äº° ¹× ¸®°£µå ÇǽÌÀ» À§ÇÑ ´Ü¹éÁúüÇÐ, ÇÏÀ̽º·çDz ½ºÅ©¸®´×(HTS)À» À§ÇÑ ºÐ¼® °ËÁõ, ºü¸¥ ģȭµµ ·©Å·, Ç¥Àû ´Ü¹éÁú¿¡ °áÇÕÇÏ´Â ÀúºÐÀÚ È­ÇÕ¹°ÀÇ Á¤È®ÇÑ »óÈ£ÀÛ¿ë ¼Óµµ·Ð µî¿¡ ³Î¸® Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. µî¿¡ ³Î¸® Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸®µå È­ÇÕ¹° ÃÖÀûÈ­, Ãʱâ ADME, ÀÓ»ó½ÃÇè¿¡¼­ Ä¡·áÁ¦¿¡ ´ëÇÑ È¯ÀÚ ¹ÝÀÀ¼º °èÃþÈ­, ¹ÙÀÌ¿À Ä¡·áÁ¦ÀÇ Ç׾๰ Ç×ü(ADA) ¹ÝÀÀÀ» Æ÷ÇÔÇÑ ¸é¿ª¿ø¼º Æò°¡, ¸é¿ª ¹ÝÀÀ ºÐ¼®À» Æ÷ÇÔÇÑ ¹é½Å °³¹ß, ±×¸®°í Ä¡·á¿ë Ç×ü ¹× ´Ü¹éÁúÀÇ °øÁ¤ ¹× ¹èÄ¡ QC µîÀÇ Á¦Á¶¿¡µµ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

AnalystView Market InsightsÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®µéÀÌ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 5.50%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç° ¼¼ºÐÈ­¸¦ ±âÁØÀ¸·Î º¼ ¶§, À̹Ì¡ ½Ã½ºÅÛ ºÎ¹®ÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.

¿ëµµº°·Î´Â ½Å¾à°³¹ß ºÐ¾ß°¡ °¡Àå ¸¹Àº ¸ÅÃâÀ» âÃâÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¸ÅÃâ¿¡¼­ ¼±µÎ¸¦ Â÷ÁöÇß½À´Ï´Ù.

Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀåÀº Á¦Ç°, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç°¿¡ µû¶ó À̹Ì¡ ½Ã½ºÅÛ, ¼¾¼­ ½Ã½ºÅÛ, ½Ã¾àÀÇ ¼¼ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. À̹Ì¡ ½Ã½ºÅÛ Ä«Å×°í¸®°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ºÐÀÚ °£ »óÈ£ ÀÛ¿ëÀÇ ½Ç½Ã°£ À̹Ì¡¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿¬±¸ »ý»ê¼ºÀÌ Çâ»óµÇ°í ½Å¾à °³¹ß ÇÁ·Î¼¼½º°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ À̹Ì¡ ±â¼úÀÇ ¹ßÀüÀ¸·Î °¨µµ¿Í ÇØ»óµµ°¡ Çâ»óµÇ¾î µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀåÀº ¿ëµµ¿¡ µû¶ó ½Å¾à °³¹ß, Àç·á °úÇÐ, ¹ÙÀÌ¿À ¼¾¼­ µî ¼¼ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ½Å¾à°³¹ß ºÐ¾ß°¡ °¡Àå ³ôÀº ¼ÒµæÀ» ¿Ã·È´Ù(58%). ºÐÀÚ°£ »óÈ£ ÀÛ¿ëÀÇ Á¤¹ÐÇÏ°í ½Å¼ÓÇÑ Á¶»ç¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó »õ·Î¿î Ä¡·á Èĺ¸ ¹°ÁúÀÇ ½Äº° ¹× ÃÖÀûÈ­°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦¾àȸ»çµéÀÌ ½Å¾à °³¹ß ½Ãµµ¸¦ °­È­ÇÔ¿¡ µû¶ó SPR ±â¼úÀÇ ¹ü¿ë¼º°ú È¿À²¼ºÀÌ Á¡Á¡ ´õ Áß¿äÇØÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå - Áö¿ªÀû ÀλçÀÌÆ®

Áö¿ªÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«À¸·Î ³ª´¹´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ °¡Á® ¿À´Â ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µË´Ï´Ù. ºÏ¹ÌÀÇ Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀåÀÌ ÀÌ ½ÃÀåÀ» ÁÖµµÇÏ´Â ÀÌÀ¯´Â ÀÌ Áö¿ªÀÇ °­·ÂÇÑ Á¦¾à ¹× »ý¸í°øÇÐ ºÎ¹®°ú SPR°ú °°Àº ÷´Ü ºÐ¼® ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÏ´Â ¿¬±¸°³¹ß¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ·Î ÀÎÇØ ÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀåÀº 2023-2032³â °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±Þ¼ÓÇÑ »ê¾÷È­, ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ¸ÂÃãÇü Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç¥¸é ÇöóÁî¸ó °ø¸í ¸ÅÃâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Áß±¹ÀÇ Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀåÀÌ °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ÀεµÀÇ Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀåÀº ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå - °æÀï ±¸µµ:

Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀåÀÇ ÁÖ¿ä °æÀï»çÀÎ *Biacore(GE Healthcare¿¡ ÀμöµÈ Biacore), Bio-Rad Laboratories, Attana AB, Nicoya, BioNavis Ltd. µîÀº R&D »ç¾÷¿¡ ÅõÀÚÇÏ¿© ½ÃÀå ¼ö¿ä¸¦ ´Ã¸®·Á Çϰí Çϰí ÀÖ½À´Ï´Ù. À̵é ÁÖ¿ä ±â¾÷Àº °æÀï ¿ìÀ§¸¦ À¯ÁöÇÏ°í º¯È­ÇÏ´Â °í°´ ´ÏÁî¿¡ ´ëÀÀÇϱâ À§ÇØ M&A, Á¦ÈÞ, Á¦Ç° ¹ßÇ¥ µîÀÇ ¹æ¹ýÀ» »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ±â¼ú °³¼± ¹× SPR ½Ã½ºÅÛ Çõ½Å°ú °°Àº ½ÃÀå °³Ã´Àº ¾÷°èÀÇ °æÀï ¿ªÇп¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå °³¿ä

Á¦2Àå °³¿ä

Á¦3Àå Ç¥¸é ÇöóÁî¸ó °ø¸í ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå Ç¥¸é ÇöóÁî¸ó °ø¸í »ê¾÷ ¿¬±¸

Á¦5Àå Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå : COVID-19 ¿µÇ⠺м®

Á¦6Àå Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå ±¸µµ

Á¦7Àå Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå - Á¦Ç°º°

Á¦8Àå Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå - ¿ëµµº°

Á¦9Àå Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå Ç¥¸é ÇöóÁî¸ó °ø¸í ½ÃÀå - Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - Ç¥¸é ÇöóÁî¸ó °ø¸í ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Surface Plasmon Resonance Market size was valued at USD 1,125.2 Million in 2023, expanding at a CAGR of 5.50% from 2024 to 2032.

Surface Plasmon Resonance (SPR) is a technology for tracking label-free biomolecular interactions in real-time. This process involves immobilizing one of the molecules on a metallic sheet. A metallic film is typically constructed of gold because it emits an SPR signal at favorable combinations of reflectance angle and wavelength. Surface plasmons are utilized to increase the surface sensitivity of many spectroscopic tests, including fluorescence, Raman scattering, and second-harmonic generation.

Surface Plasmon Resonance Market- Market Dynamics

Increasing Application of Surface Plasmon Resonance in the Field of Drug Discovery

Increasing use of surface plasmon resonance by key industry players is likely to drive the surface plasmon resonance market during the forecast period. Surface plasmon resonance technology has a significant impact on drug discovery and development. Small molecule drug research and development is recognized to be an expensive and time-consuming endeavor that does not always succeed. Surface plasmon resonance is widely utilized in proteomics for target identification and ligand fishing, assay validation for High Throughput Screening (HTS), fast affinity ranking, and precise kinetics of interaction for small compounds binding to target proteins. It is also used in lead optimization, early ADME, stratification of patient response to therapeutics in clinical trials, immunogenicity assessment, including anti-drug antibody (ADA) responses of biotherapeutics, vaccine development, including immune response analysis, and even manufacturing, such as process and batch QC of therapeutic antibodies and proteins.

Surface Plasmon Resonance Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.50% over the forecast period (2024-2032)

Based on Product segmentation, The imaging systems segment dominated the market.

Based on application segmentation, The drug discovery segment generated the most revenue.

On the basis of region, North America was the leading revenue generator in 2023

Surface Plasmon Resonance Market- Segmentation Analysis:

The Global Surface Plasmon Resonance Market is segmented on the basis of Product, Application, End User, and Region.

The market is divided into three categories based on Product: Imaging System, Sensor System, and Reagents. The imaging system category dominated the market. The growing demand for real-time imaging of molecular interactions which improves research productivity and speeds up drug discovery processes. Furthermore, advances in imaging technology provide increased sensitivity and resolution, accelerating adoption.

The market is divided into three categories based on application: Drug Discovery, Material Science and Biosensors. The drug discovery category had the highest income (58%). The increasing requirement for precise and quick investigation of bimolecular interactions has accelerated the identification and optimization of new treatment candidates. Furthermore, as pharmaceutical companies ramp up their attempts to create novel medicines, the versatility and efficiency of SPR technology become increasingly important, boosting market growth.

Surface Plasmon Resonance Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. The North American surface plasmon resonance market will lead this market because to the region's strong pharmaceutical and biotechnology sectors, as well as significant investments in R&D, which drive demand for advanced analytical technologies such as SPR.

The Asia-Pacific surface plasmon resonance market is predicted to develop at the quickest CAGR between 2023 and 2032. The Asia-Pacific area is seeing an increase in surface plasmon resonance sales due to fast industrialization, increased investment in healthcare infrastructure, and rising demand for tailored treatment. Furthermore, China's surface plasmon resonance market had the highest market share, while India's surface plasmon resonance market was the fastest expanding in Asia-Pacific.

Surface Plasmon Resonance Market- Competitive Landscape:

Major competitors in the surface plasmon resonance market, such as*Biacore (acquired by GE Healthcare), Bio-Rad Laboratories, Attana AB, Nicoya and BioNavis Ltd.are seeking to boost market demand by investing in R&D operations. These significant players use methods like as mergers and acquisitions, collaborations, and product launches to maintain their competitive advantage and meet changing client needs. Market developments, such as technology improvements and SPR system innovations, have a significant impact on the industry's competitive dynamics.

Recent Developments:

In January, 2023, GE Healthcare experienced a separation from GE, ending in the formation of GE HealthCare Technologies Inc. This successful spin-off marks a crucial step in the company's journey to three distinct organizations, each focused on growing industries.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SURFACE PLASMON RESONANCE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Biacore (acquired by GE Healthcare)

Bio-Rad Laboratories

Attana AB

Nicoya

BioNavis Ltd.

Reichert Technologies

Biosensing Instrument Inc.

GWC Technologies Inc.

Plexera Bioscience LLC

Horiba Scientific

Sensata Technologies

Carterra Inc.

AMETEK Advanced Motion Solutions

Genoptix (a Novartis company)

BiOptix Diagnostics (acquired by ForteBio)

Insplorion AB

SPR Therapeutics

Ssens BV

Kinetic Biosystems

Sierra Sensors GmbH

Others

GLOBAL SURFACE PLASMON RESONANCE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

GLOBAL SURFACE PLASMON RESONANCE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL SURFACE PLASMON RESONANCE MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL SURFACE PLASMON RESONANCE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Surface Plasmon Resonance Market Overview

2. Executive Summary

3. Surface Plasmon Resonance Key Market Trends

4. Surface Plasmon Resonance Industry Study

5. Surface Plasmon Resonance Market: COVID-19 Impact Analysis

6. Surface Plasmon Resonance Market Landscape

7. Surface Plasmon Resonance Market - By Product

8. Surface Plasmon Resonance Market - By Application

9. Surface Plasmon Resonance Market - By End User

10. Surface Plasmon Resonance Market- By Geography

11. Key Vendor Analysis- Surface Plasmon Resonance Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â